TABLE 2

Parameters for agonist and/or antagonist action at hα 4β 2-nA ChR.

86Rb+ efflux assays were conducted as described under Materials and Methods and in the legends to Figs. 7 and 8. Results were fit to the logistic equation to determine log EC50 values (for agonists) or IC50 values (for antagonists) and Hill coefficients (presented ± S.E.M.). Functional log IC50 values and Hill numbers given in parentheses for nicotine and suberyldicholine are from fits to the self-inhibitory phase of agonist dose-response profiles for those drugs.

Drug log EC50nh log IC50nh
Epibatidine −8.07 ± 0.08 1.12 ± 0.22
Nicotine −6.07 ± 0.21 0.79 ± 0.21 (−2.24 ± 0.93) (−0.76 ± 1.15)
Cytisine −5.90 ± 0.32 0.67 ± 0.31
Suberyldicholine −5.89 ± 0.19 1.15 ± 0.39 (−3.69 ± 0.23) (−0.95 ± 0.35)
−3.44 ± 0.34 −0.91 ± 0.28
ACh −5.77 ± 0.08 0.67 ± 0.07
DMPP −5.72 ± 0.19 0.84 ± 0.26
Carbamylcholine −4.78 ± 0.07 1.18 ± 0.19
Acetylthiocholine −4.00 ± 0.06 1.25 ± 0.16
Choline <−3
Mecamylamine −6.33 ± 0.05 −1.17 ± 0.15
DHβE −5.82 ± 0.05 −1.36 ± 0.19
MLA −5.18 ± 0.05 −1.28 ± 0.15
Hexamethonium −4.97 ± 0.07 −1.42 ± 0.25
Lobeline −4.68 ± 0.07 −1.18 ± 0.20
Alcuronium −4.59 ± 0.05 −1.26 ± 0.13
Vecuronium −4.56 ± 0.03 −1.51 ± 0.15
d-Tubocurarine −4.21 ± 0.07 −1.19 ± 0.19
Pancuronium −4.04 ± 0.08 −1.04 ± 0.18
Eserine −3.89 ± 0.05 −1.34 ± 0.19
Decamethonium −3.52 ± 0.07 −1.24 ± 0.16
Succinylcholine ≪−3